Clinical Trials
3 trialsNCT07490990 2026-03-24
A Real-World, Single-Arm Study Protocol of Disitamab Vedotin in Combination With Immunotherapy and Multimodal Radiation Therapy for HER2-Positive Advanced Gastric Cancer: After Second-Line Treatment Failure
West China Hospital
Not yet recruiting
NCT05851677 2025-09-17
Disitamab Vedotin (RC48-ADC) in Breast Cancer
RenJi Hospital
Recruiting
NCT05649163 2022-12-16
Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy
Peking University
Unknown